3QXA: HLA-DR1
HLA-DR1 bound with CLIP peptide. Determined by X-ray diffraction at 2.71 Å resolution. Released 16 Nov 2011.
- Method
- X-ray diffraction
- Resolution
- 2.71 Å
- Organism
- Homo sapiens
- Chains
- 6
- Atoms
- 6,407
- Mol. weight
- 89.83 kDa
- Released
- 16 Nov 2011
Explore 3QXA in 3D
Show helices and sheets
RCSB PDB
PDBe
Secondary structure: helices and β-sheets
3QXA contains 27 α-helices and 64 β-strands across 6 chains. Residue ranges use author residue numbering, as in the PDB file, from PDBe. To see them in 3D, choose the Cartoon representation with Secondary structure coloring: helices, sheets and coils get different colors.
Chain A: 5 helices, 16 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 5-15 | 11 | 1 |
| β-strand | 19-26 | 8 | 1 |
| β-strand | 29-35 | 7 | 1 |
| β-strand | 40-43 | 4 | 1 |
| α-helix | 46-50 | 5 | |
| β-strand | 53 | 1 | 2 |
| α-helix | 57-76 | 20 | |
| α-helix | 81-83 | 3 | |
| β-strand | 85 | 1 | 3 |
| α-helix | 86-87 | 2 | |
| β-strand | 88-93 | 6 | 4 |
| β-strand | 103-112 | 10 | 4 |
| β-strand | 113 | 1 | 3 |
| β-strand | 118-123 | 6 | 5 |
| β-strand | 126-128 | 3 | 5 |
| β-strand | 133-134 | 2 | 4 |
| α-helix | 137 | 1 | |
| β-strand | 138-139 | 2 | 4 |
| β-strand | 145-153 | 9 | 4 |
| β-strand | 160-166 | 7 | 5 |
| β-strand | 174-179 | 6 | 5 |
Chain B: 7 helices, 15 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 7-18 | 12 | 1 |
| β-strand | 23-32 | 10 | 1 |
| β-strand | 35-41 | 7 | 1 |
| β-strand | 46-49 | 4 | 1 |
| α-helix | 52-54 | 3 | |
| α-helix | 55-62 | 8 | |
| α-helix | 65-74 | 10 | |
| α-helix | 75-80 | 6 | |
| α-helix | 81-86 | 6 | |
| α-helix | 87-89 | 3 | |
| β-strand | 95 | 1 | 6 |
| α-helix | 96-97 | 2 | |
| β-strand | 98-103 | 6 | 7 |
| β-strand | 113-122 | 10 | 7 |
| β-strand | 123 | 1 | 6 |
| β-strand | 128-133 | 6 | 8 |
| β-strand | 136-137 | 2 | 8 |
| β-strand | 142-144 | 3 | 7 |
| β-strand | 148-149 | 2 | 7 |
| β-strand | 155-163 | 9 | 7 |
| β-strand | 170-176 | 7 | 8 |
| β-strand | 184-189 | 6 | 8 |
Chain C: 2 helices, 1 β-strand
| Element | Residues | Length | Sheet |
|---|
| β-strand | 90 | 1 | 2 |
| α-helix | 91-92 | 2 | |
| α-helix | 94-98 | 5 | |
Chain D: 6 helices, 16 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 5-15 | 11 | 9 |
| β-strand | 19-26 | 8 | 9 |
| β-strand | 29-35 | 7 | 9 |
| β-strand | 40-43 | 4 | 9 |
| α-helix | 46-50 | 5 | |
| β-strand | 53 | 1 | 10 |
| α-helix | 56-76 | 21 | |
| α-helix | 80-84 | 5 | |
| β-strand | 85 | 1 | 11 |
| α-helix | 86-87 | 2 | |
| β-strand | 88-93 | 6 | 12 |
| β-strand | 103-112 | 10 | 12 |
| β-strand | 113 | 1 | 11 |
| β-strand | 118-123 | 6 | 13 |
| β-strand | 126-128 | 3 | 13 |
| β-strand | 133-134 | 2 | 12 |
| α-helix | 137 | 1 | |
| β-strand | 138-139 | 2 | 12 |
| β-strand | 145-153 | 9 | 12 |
| β-strand | 161-166 | 6 | 13 |
| α-helix | 173 | 1 | |
| β-strand | 174-178 | 5 | 13 |
Chain E: 7 helices, 15 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 7-18 | 12 | 9 |
| β-strand | 23-32 | 10 | 9 |
| β-strand | 35-41 | 7 | 9 |
| β-strand | 47-49 | 3 | 9 |
| α-helix | 52-54 | 3 | |
| α-helix | 55-61 | 7 | |
| α-helix | 65-74 | 10 | |
| α-helix | 75-80 | 6 | |
| α-helix | 81-86 | 6 | |
| β-strand | 95 | 1 | 14 |
| α-helix | 96-97 | 2 | |
| β-strand | 98-103 | 6 | 15 |
| β-strand | 113-122 | 10 | 15 |
| β-strand | 123 | 1 | 14 |
| β-strand | 128-133 | 6 | 16 |
| β-strand | 136-138 | 3 | 16 |
| β-strand | 142-144 | 3 | 15 |
| β-strand | 148-149 | 2 | 15 |
| β-strand | 155-163 | 9 | 15 |
| β-strand | 170-176 | 7 | 16 |
| α-helix | 183 | 1 | |
| β-strand | 184-189 | 6 | 16 |
Chain F: 0 helices, 1 β-strand
| Element | Residues | Length | Sheet |
|---|
| β-strand | 90 | 1 | 10 |
Molecules and chains
| Molecule | Chains | Type | Length | Organism | UniProt |
|---|
| HLA class II histocompatibility antigen, DR alpha chain | A, D | protein | 182 | Homo sapiens | P01903 (AlphaFold model) |
| HLA class II histocompatibility antigen, DRB1-1 beta chain | B, E | protein | 190 | Homo sapiens | P01911 (AlphaFold model) |
| HLA class II histocompatibility antigen gamma chain peptide | C, F | protein | 15 | Homo sapiens | P04233 (AlphaFold model) |
Sequence of entity 1 (A, D), FASTA
>3QXA_1 HLA class II histocompatibility antigen, DR alpha chain (chains A, D)
IKEEHVIIQAEFYLNPDQSGEFMFDFDGDEIFHVDMAKKETVWRLEEFGRFASFEAQGAL
ANIAVDKANLEIMTKRSNYTPITNVPPEVTVLTNSPVELREPNVLICFIDKFTPPVVNVT
WLRNGKPVTTGVSETVFLPREDHLFRKFHYLPFLPSTEDVYDCRVEHWGLDEPLLKHWEF
DA
Sequence of entity 2 (B, E), FASTA
>3QXA_2 HLA class II histocompatibility antigen, DRB1-1 beta chain (chains B, E)
GDTRPRFLWQLKFECHFFNGTERVRLLERCIYNQEESVRFDSDVGEYRAVTELGRPDAEY
WNSQKDLLEQRRAAVDTYCRHNYGVGESFTVQRRVEPKVTVYPSKTQPLQHHNLLVCSVS
GFYPGSIEVRWFRNGQEEKAGVVSTGLIQNGDWTFQTLVMLETVPRSGEVYTCQVEHPSV
TSPLTVEWRA
Sequence of entity 3 (C, F), FASTA
>3QXA_3 HLA class II histocompatibility antigen gamma chain peptide (chains C, F)
PVSKMRMATPLLMQA
Primary citation
Conformational lability in the class II MHC 310 helix and adjacent extended strand dictate HLA-DM susceptibility and peptide exchange. Painter, C.A., Negroni, M.P., Kellersberger, K.A. et al. Proc Natl Acad Sci U S A (2011) 108:19329-19334. DOI 10.1073/pnas.1108074108 · PubMed
Other PDB entries of the same protein (UniProt P01903 (AlphaFold model), which also has an AlphaFold model), best resolution first:
- 5NI9 1.33 Å, Crystal structure of HLA-DRB1*04:01 with the alpha-enolase peptide 326-340
- 4X5W 1.34 Å, HLA-DR1 with CLIP102-120(M107W)
- 5NIG 1.35 Å, Crystal structure of HLA-DRB1*04:01 with modified alpha-enolase peptide 326-340…
- 8CMC 1.42 Å, Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 Spike peptide S511-530
- 8PJF 1.48 Å, Human Leukocyte Antigen class II allotype DR1 presenting P11T->R modified influenza A…
- 6QZC 1.64 Å, HLA-DR1 with the QAR Peptide
- 8CMG 1.64 Å, Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 nsp14 peptide…
- 8CMH 1.64 Å, Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 Omicron (BA.1) Spike…
- 4MD5 1.65 Å, Immune Receptor
- 4MDJ 1.7 Å, Immune Receptor
- 8PJE 1.7 Å, Human Leukocyte Antigen class II allotype DR1 presenting influenza A virus…
- 7YX9 1.76 Å, MHC-II dynamics are maintained in HLA-DR allotypes to ensure catalyzed peptide exchange
Browse structure collections
About this viewer
MolViewer shows 3QXA directly in your browser with nothing to install. Switch between cartoon, ball-and-stick, spacefill and surface views, color by chain, secondary structure or B-factor, measure distances, angles and dihedrals, and share or embed the view.